Terns Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNJun 5

   Ownership stake disclosure by Stanley Morgan (amended)

   Stanley Morgan, filed by

2. ROUTINE15-12GTerns Pharmaceuticals, Inc.TERNMay 15

   Deregistration notice

3. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNMay 13

   Ownership stake disclosure by Adage Capital Management, L.P. (amended)

   Adage Capital Management, L.P., filed by

4. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNMay 12

   Ownership stake disclosure by Stanley Morgan (amended)

   Stanley Morgan, filed by

5. ROUTINEEFFECTTerns Pharmaceuticals, Inc.TERNMay 8

   Registration declared effective

6. ROUTINE4Terns Pharmaceuticals, Inc.TERNMay 5

   9 insider filings

   Robert Azelby, insider filing for TERN

   Show all 9

   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5
   • 4Insider filing for TERNMay 5

   Robert Azelby, reporting

7. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

   S-8 POS filing

8. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

   S-8 POS filing

9. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

   S-8 POS filing

10. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

    S-8 POS filing

11. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

    S-8 POS filing

12. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

    S-8 POS filing

13. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

    S-8 POS filing

14. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

    S-8 POS filing

15. ROUTINES-8 POSTerns Pharmaceuticals, Inc.TERNMay 5

    S-8 POS filing

16. ROUTINEPOS AMTerns Pharmaceuticals, Inc.TERNMay 5

    POS AM filing

17. ROUTINEPOSASRTerns Pharmaceuticals, Inc.TERNMay 5

    POSASR filing

18. ROUTINE8-KTerns Pharmaceuticals, Inc.TERNMay 5

    Current report

19. ROUTINESC 14D9/ATerns Pharmaceuticals, Inc.TERNMay 5

    Tender offer response (amended)

20. NOTABLE25-NSETerns Pharmaceuticals, Inc.TERNMay 5

    Delisting notice

    Nasdaq Stock Market LLC, filed by

21. ROUTINESC TO-T/ATerns Pharmaceuticals, Inc.TERNMay 5

    Tender offer (amended)

    Merck & Co., Inc., filed by

22. ROUTINE10-K/ATerns Pharmaceuticals, Inc.TERNApr 27

    Annual report (amended)

23. ROUTINE8-KTerns Pharmaceuticals, Inc.TERNApr 27

    Current report

24. ROUTINESC 14D9/ATerns Pharmaceuticals, Inc.TERNApr 24

    Tender offer response (amended)

25. ROUTINESC TO-T/ATerns Pharmaceuticals, Inc.TERNApr 24

    Tender offer (amended)

    Merck & Co., Inc., filed by

26. NOTABLESC 14D9Terns Pharmaceuticals, Inc.TERNApr 7

    Tender offer response

27. NOTABLESC TO-TTerns Pharmaceuticals, Inc.TERNApr 7

    Tender offer

    Merck & Co., Inc., filed by

28. ROUTINE4Terns Pharmaceuticals, Inc.TERNApr 2

    Emil Kuriakose, insider filing for TERN

    Emil Kuriakose, reporting

29. ROUTINES-8Terns Pharmaceuticals, Inc.TERNMar 30

    Employee stock plan registration

30. NOTABLE10-KTerns Pharmaceuticals, Inc.TERNMar 30

    Annual report

31. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNMar 27

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

32. ROUTINESC TO-CTerns Pharmaceuticals, Inc.TERNMar 26

    SC TO-C filing

    MERCK SHARP & DOHME LLC, filed by

33. ROUTINESC14D9CTerns Pharmaceuticals, Inc.TERNMar 25

    SC14D9C filing

34. ROUTINESC TO-CTerns Pharmaceuticals, Inc.TERNMar 25

    SC TO-C filing

    MERCK SHARP & DOHME LLC, filed by

35. ROUTINESC14D9CTerns Pharmaceuticals, Inc.TERNMar 25

    SC14D9C filing

36. ROUTINESC TO-CTerns Pharmaceuticals, Inc.TERNMar 25

    SC TO-C filing

    MERCK SHARP & DOHME LLC, filed by

37. ROUTINE8-KTerns Pharmaceuticals, Inc.TERNMar 25

    Current report

38. ROUTINE4Terns Pharmaceuticals, Inc.TERNMar 17

    Amy L. Burroughs, insider filing for TERN

    Amy L. Burroughs, reporting

39. ROUTINE4Terns Pharmaceuticals, Inc.TERNFeb 18

    Amy L. Burroughs, insider filing for TERN

    Amy L. Burroughs, reporting

40. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNFeb 17

    Ownership stake disclosure by Commodore Capital LP (amended)

    Commodore Capital LP, filed by

41. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNFeb 13

    Ownership stake disclosure by Vivo Opportunity Fund Holdings, L.P. (amended)

    Vivo Opportunity Fund Holdings, L.P., filed by

42. ROUTINESCHEDULE 13G/ATerns Pharmaceuticals, Inc.TERNFeb 13

    Ownership stake disclosure by Deep Track Capital, LP (amended)

    Deep Track Capital, LP, filed by

Older filings on EDGAR